Detall de la convocatòria

Característiques

Característica
Característiques principals
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology.
The Institute seeks hypothesis driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor must clearly state the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumors and/or the treatment of cancer.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.1670
Marta López: mlopez4@imim.es, Ext.: 1576
Convocatòria (URL)
http://www.cancerresearch.org/postdoc/apply
Informació addicional
The application deadlines are April 1 and October 1; when those dates fall on the weekend, applications are due the following Monday. Applications are due by 5 p.m. EST on these dates.
Requisits
  • Applicants for the CRI Irvington Postdoctoral Fellowship Program must be working in areas directly related to cancer immunology. An eligible project must fall into the broad field of immunology and must show relevance to solving the cancer problem. Proposals that do not encompass both these areas will not be considered.
  • Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
  • Applicants with 5 or more years of relevant postdoctoral experience are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
  • Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
  • The fellowship can be performed in the United States or abroad, but must take place at a non-profit institution. There are no citizenship restrictions.
  • Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
    • Dotació
    The fellowship provides a stipend of $50,000 for the first year, $53,000 for the second year, and $57,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, and/or health insurance.
    Durada
    3 years
    Documentació
    After you have filled out all required fields on the online application, you will be asked on the final page of the application to upload, in this order, the following supporting documentation in one PDF document:
    1. The entire PDF application form, beginning with the cover sheet. Please make sure all signatures have been obtained for section three.
    2. Brief description of the applicant's background and research accomplishments.
    3. List of other funding sources to which applications have been or will be submitted, with due dates.
    4. Applicant’s curriculum vitae and bibliography.
    5. Brief summary of your project, including a description of how the proposed research is relevant to understanding the role of the immune system in cancer and/or the treatment of cancer through immunological means. Relevance to cancer immunology must also be reflected throughout the research proposal (see item #7).
    6. Abstract of research in non-technical English explaining the importance of the proposed research and its potential clinical relevance. The abstract will be used for fundraising purposes and submitted to CRI’s lay Board of Trustees.
    7. Concise research proposal (background, significance, specific aims, materials and methods) not to exceed 6 pages inclusive of tables and figures, exclusive of references. Applications exceeding this page limit will be disqualified.
    8. *Letter from the sponsor introducing the applicant and describing the sponsor’s qualifications to direct the proposed research. The letter must contain assurance that the applicant’s project will be conducted under the direct supervision of the sponsor. The sponsor should also emphasize the relevance of the proposed project to cancer immunology.
    9. *Sponsor’s curriculum vitae, bibliography (limit bibliography to past 5 years or to publications relevant to proposed research) and a list of sponsor’s current research support.
    10. *Two letters of recommendation are required. One letter must be from the applicant’s thesis advisor. Applicants who received an M.D. or otherwise who do not have a thesis advisor should have some other qualified individual submit this letter. The second letter should be from an individual well acquainted with the applicant’s work. The sponsor may not submit one of these letters. If the sponsor was also the applicant's thesis advisor, you must contact CRI for further instruction.

    Arxius

    Arxiu
    Guidelines